viewTHC Global Group Ltd

The Hydroponics Company imports first batch of medicinal cannabis oils from Europe

Approved Australian patients will be able to access products under the government’s Special Access Scheme.

medicinal cannabis
All products will be available at www.mcmp.com.au

The Hydroponics Company Ltd (ASX:THC) has received the first medicinal cannabis products from its strategic alliance partner in Denmark, Endoca.

The initial shipment of medicinal cannabis oils from Endoca will be accessible to patients and healthcare professionals in Australia through the Medicinal Cannabis Medicines Portal (MCMP).

The MCMP (www.mcmp.com.au) significantly streamlines the process required for doctors to prescribe medicinal cannabis to Australian patients via the Special Access Scheme.

Supply will start within weeks

THC has permits in place to begin distributing medicinal cannabis products from Endoca. Australian patients will have access under the Special Access Scheme or through an Approved Prescriber.

Supply will be available in the market within weeks.

The import of these products represents a significant development in advancing the medicinal cannabis industry in Australia, and most importantly, making high quality products available to patients in need.

THC chairman Steven Xu said: “THC’s program to bring Endoca products to Australia is the first step in providing Australia with high quality medicinal cannabis solutions, which will extend to local organic growing and pharmaceutical GMP manufacture as we roll out our partner and domestic production strategy.”

READ: The Hydroponics Company welcomes Canadian bill to legalise recreational cannabis

THC also stands to gain from the C-45 Bill that has been passed by Canada’s senate on June 7 to legalise adult recreational use of cannabis in Canada.

Canada is the largest developed nation to legalise nationwide recreational use for adults over the age of 18.

The Cannabis Act is a milestone toward the end of prohibition of recreational cannabis in Canada and is expected to be an important driver of growth for THC’s hydroponics division.

Quick facts: THC Global Group Ltd

Price: 0.405 AUD

Market: ASX
Market Cap: $59.14 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of THC Global Group Ltd named herein, including the promotion by the Company of THC Global Group Ltd in any Content on the Site, the Company...



Full interview: THC Global Group granted GMP Licence for Southport cannabis...

THC Global Group Limited (ASX:THC) chief executive officer Ken Charteris updates Proactive on being granted a licence to manufacture therapeutic goods for the company’s Southport Facility, known as a GMP Licence, by the Australian Therapeutic Goods Administration (TGA). This milestone...

on 29/1/20

2 min read